These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 360761)

  • 1. Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias.
    Lindeboom SF; Lakke JP
    Acta Neurol Scand; 1978 Aug; 58(2):134-8. PubMed ID: 360761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deanol acetamidobenzoate treatment in choreiform movement disorders.
    Tarsy D; Bralower M
    Arch Neurol; 1977 Dec; 34(12):756-8. PubMed ID: 145212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deanol in the treatment of levodopa-induced dyskinesias.
    Klawans HL; Topel JL; Bergen D
    Neurology; 1975 Mar; 25(3):290-3. PubMed ID: 1167639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deanol in the management of involuntary movement disorders: a review.
    Casey DE
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):7-15. PubMed ID: 145359
    [No Abstract]   [Full Text] [Related]  

  • 5. Deanol in the treatment of tardive dyskinesia.
    Simpson GM; Voitashevsky A; Young MA; Lee JH
    Psychopharmacology (Berl); 1977 May; 52(3):257-61. PubMed ID: 406628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic influences in tardive dyskinesia.
    Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
    Jus A; Villeneuve A; Gautier J; Jus K; Villeneuve C; Pires P; Villeneuve R
    Neuropsychobiology; 1978; 4(3):140-9. PubMed ID: 340975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind evaluation of deanol in tardive dyskinesia.
    Penovich P; Morgan JP; Kerzner B; Karch F; Goldblatt D
    JAMA; 1978 May; 239(19):1997-8. PubMed ID: 347112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.
    de Montigny C; Chouinard G; Annable L
    Psychopharmacology (Berl); 1979 Nov; 65(3):219-23. PubMed ID: 117492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of tardive dyskinesia.
    Casey DE; Denney D
    Psychopharmacology (Berl); 1977 Aug; 54(1):1-8. PubMed ID: 410053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double blind controlled trial of deanol in tardive dyskinesia.
    George J; Pridmore S; Aldous D
    Aust N Z J Psychiatry; 1981 Mar; 15(1):68-71. PubMed ID: 6942835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deanol in L-dopa and tardive dyskinesias: a review.
    Osvaldo NR
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):872-5. PubMed ID: 813952
    [No Abstract]   [Full Text] [Related]  

  • 14. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
    Svenningsson P; Rosenblad C; Af Edholm Arvidsson K; Wictorin K; Keywood C; Shankar B; Lowe DA; Björklund A; Widner H
    Brain; 2015 Apr; 138(Pt 4):963-73. PubMed ID: 25669730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Deanol in tardive dyskinesia: a double-blind study (author's transl)].
    Bockenheimer S; Lucius G
    Arch Psychiatr Nervenkr (1970); 1976 Sep; 222(1):69-75. PubMed ID: 791197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood alterations during deanol therapy.
    Casey DE
    Psychopharmacology (Berl); 1979 Apr; 62(2):187-91. PubMed ID: 111283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone in levodopa-induced dyskinesias.
    Bonifati V; Fabrizio E; Cipriani R; Vanacore N; Meco G
    Clin Neuropharmacol; 1994 Feb; 17(1):73-82. PubMed ID: 8149361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate in the treatment of levodopa-induced dyskinesia.
    Price PA; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):702-6. PubMed ID: 355601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deanol in the treatment of levodopa-induced dyskinesias.
    Miller E
    Neurology; 1974 Feb; 24(2):116-9. PubMed ID: 4855678
    [No Abstract]   [Full Text] [Related]  

  • 20. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.
    Stafford JR; Fann WE
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):3-6. PubMed ID: 590063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.